An interventional study of Speech Therapy and Proprioceptive treatment in Developmental Dyslexia, sponsored by Scalab CNRS 9193. Status unknown at 1 site in France. Open to participants aged 9 Years to 14 Years. Per ClinicalTrials.gov, last updated 2020-03-17.
Sponsored by Scalab CNRS 9193 · Not applicable, Interventional, and Treatment
Among 27 studies in Dyslexia with a site in France — 2 open to participants now, 3 under way, none of them phase 3. Dyslexia · France.
Among the 27 studies in Dyslexia with a site in France, this one is the 16th largest by planned enrollment of the 22 interventional ones, is one of 3 that started in 2018, is one of 22 with no phase, and was the 12th registered.
127 studies on the registry are indexed under Dyslexia; 27 are open to participants now.
This study's planned enrollment of 26 is below the median of 71 across 106 interventional studies indexed under Dyslexia.
Browse Dyslexia studies →2 of the 27 studies in Dyslexia with a site in France are open now, in 1 country. Each count lists the studies.
Of the 18 Dyslexia studies recruiting now, 2 (11%) set no upper age limit and 14 (78%) stop at 75 or younger; 13 take children under 18; 11 take healthy volunteers.
This study: 9 Years to 14 Years · all sexes · no healthy volunteers.
The full table on the hub →27 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 3 started in 2018.
Median enrollment 61 across the 22 interventional studies, 161 across the 5 observational. Of the 22 that completed or were terminated, 0 (0%) have results posted.
7 of 27 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Scalab CNRS 9193 as lead sponsor.
Scalab CNRS 9193 has 1 study filed under Dyslexia — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 27 studies in Dyslexia with a site in France, from their registry updates:
To show the interest of the association of proprioceptive and orthophonic care of dyslexic children. The assumption is that proprioceptive support by correcting a centrally located spatial localization instability restores the ability to automate.
It allows a gain of effectiveness of the orthophonic remediation of the reading of dyslexic children.
Interventional comparative study over 9 months, of three modes of care: Speech-language, or proprioceptive, or combined (speech therapy or proprioceptive)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Speech therapy adapted to the child,
Other: Speech Therapy
Association of speech therapy and proprioceptive treatment, adapted to the child.
Other: Speech Therapy · Other: Proprioceptive treatment
Speech therapy adapted to the child, at least 25 sessions over 9 months.
Also known as: Orthophonic treatment
Proprioceptive treatment adapted to the child. This treatment aims to stabilize a central reference instability revealed to Maddox Postural by the use of neurosensory decoys:: * Proprioceptive stimulation of oculomotor muscles (active prisms). * Oral somatosensory stimulation (ALPH). * Proprioceptive antigravity stimulation (proprioceptive sole). * Proprioceptive reprogramming exercise. Following the teaching of the University Diploma: Perception-Action, Learning Disorders (University of Bourgogne, France)
Change from baseline C index ( Alouatte-R test) at 9 months
Number of correctly read words (standard deviation)
Time frame: Baseline, at nine months
Change from baseline TL index ( Alouatte-R test) at 9 months
Reading time in second (TL) (standard deviation)
Time frame: Baseline, at nine months
Change from baseline M index ( Alouatte-R test) at 9 months
Number of words read (M)(standard deviation)
Time frame: Baseline, at nine months
Change from baseline E index ( Alouatte-R test) at 9 months
Number of errors (E)(standard deviation)
Time frame: Baseline, at nine months
Change from baseline CM index ( Alouatte-R test) at 9 months
Precision index (CM)(standard deviation)
Time frame: Baseline, at nine months
Change from baseline CTL index ( Alouatte-R test) at 9 months
Speed index (CTL)(standard deviation)
Time frame: Baseline, at nine months
Change from baseline Regular ODEDYS test at 9 months
Regular words reading, Screening tools for dyslexia (ODEDYS)(standard deviation)
Time frame: Baseline, at nine months
Change from baseline Irregular ODEDYS test at 9 months
Irregular words reading (standard deviation)
Time frame: Baseline, at nine months
change from baseline Pseudo-words ODEDYS test at 9 months
Pseudo-words reading (standard deviation)
Time frame: Baseline, at nine months
Change from base line DFF VOG at 9 months
Duration of first fixation (DFF), of the measured reading in Video Oculography (VOG),
Time frame: Baseline, at nine months
Change from baseline DL VOG at 9 months
Duration of look (DL), of the measured reading in Video Oculography (VOG),
Time frame: Baseline, at nine months
Change from baseline TFT VOG at 9 months
Total fixation time (TFT), of the measured reading in Video Oculography (VOG),
Time frame: Baseline, at nine months
Observation of the evolution of the shape of maxwells spots from baseline at 9 months
From the shape of Maxwell's tasks to the fovea-scope
Time frame: Baseline, at nine months
Vertical orthophoria
Comparison of the evolution of reading tests, taking into account the presence or absence of localization instability, whatever the treatment groups.
Time frame: Baseline, at nine months
Plan to share: No
Ran from Feb 2018 to primary completion in Oct 2019, 19 months.
Of 62 non-industry interventional studies with no phase under Dyslexia, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 57. This study's 19 months is below that.
Counting every sponsor, half of 69 studies reached it within 24 months; a quarter within 9 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.